Abstract:Grass carp (Ctenopharyngodon idella) is subject to a hemorrhagic disease caused by grass carp reovirus (GCRV), which can lead to mass mortality in grass carp culture, causing significant economic loss. Vaccination is the most promising strategy for the prevention of infectious diseases. Immersion vaccination is considered the most effective disease prevention method for juvenile fish because it can be implemented on many fish at once and administered without causing stress. However, immune responses by immersion vaccination are markedly less robust due to the skin barrier and insufficient antigen uptake. The display of heterologous proteins on the cell surface has been explored as a delivery system for viral antigens in veterinary and human vaccine studies. To improve the efficacy of the immersion vaccine, the major capsid protein (VP7) of GCRV was co-displayed with Aeromonas hydrophila outer membrane protein a (OmpA) and major adhesion protein (Mah) on the outer membrane surface of nonpathogenic Escherichia coli BL21 using the anchoring motif of ice-nucleation protein (Inp). The immune responses and protection efficiency against GCRV infection via both the injection and immersion routes were evaluated. The results indicated that the activities of anti-oxidant enzymes (ACP, AKP, SOD and T-AOC), as well as the expression of immune-related genes (TNF-α, IL-1β, MHCI and IgM) and specific VP7 antibody levels, were strongly increased in the grass carp from 7 to 21 days post-injection inoculation in a dose dependent manner. The cumulative mortality rates of injection-vaccinated groups were much lower than those of the control group after the GCRV challenge, and the relative percent survival (RPS) was greater than 80 %. Vitally, the surface co-display of vp7-Mah protein conferred marked protection to grass carp against GCRV infection after immersion administration (RPS >50 %); this was consistent with the production of high level of specific serum antibodies, non-specific immune responses, and the expression of immune-related genes. Moreover, the invasion analysis further showed that surface co-display of the vp7-Mah protein indeed significantly improved the invasion of E. coli BL21 (DE3) in vitro. Altogether, this study demonstrated that surface display GCRV core antigen vaccine system accompanied by invasion component from aquatic pathogenic microorganism is an effective prophylactic against GCRV viral diseases via the immersion administration approach.

Dominant antigen of grass carp Reovirus and immunity assessment with DNA vaccine for grass carp

Protective Immunity of Grass Carp Induced by DNA Vaccine Encoding Capsid Protein Gene (vp7) of Grass Carp Reovirus Using Bacterial Ghost As Delivery Vehicles.

Comparative Study of the Immunoprotective Effect of Two DNA Vaccines Against Grass Carp Reovirus.

Antigen Epitope Screening of Grass Carp Reovirus and Its Protectively Immunity Assessment for Grass Carp

Comparative Study of the Immunoprotective Effect of Two Grass Carp-Sourced Bacillus Subtilis Spore-Based Vaccines Against Grass Carp Reovirus

Oral Pcdna3.1-Vp4/vp56-flac DNA Vaccine Encapsulated by Chitosan/sodium Alginate Nanoparticles Confers Remarkable Protection Against GCRV Infection in Grass Carp

Oral Administration of Bacillus subtilis Subunit Vaccine Significantly Enhances the Immune Protection of Grass Carp against GCRV-II Infection

Oral Delivery of Bacillus Subtilis Spores Expressing Grass Carp Reovirus VP4 Protein Produces Protection Against Grass Carp Reovirus Infection.

Development of a novel candidate subunit vaccine against Grass carp reovirus Guangdong strain (GCRV-GD108).

Oral PLGA-based DNA Vaccines Using Interferons As Adjuvants Remarkably Promote the Immune Protection of Grass Carp (ctenopharyngodon Idella) Against GCRV Infection

Prokaryotic Expression, Purification and Immune Efficacy of VP6 Protein of Grass Carp Reovirus

The Protective Immunity Against Grass Carp Reovirus in Grass Carp Induced by a DNA Vaccination Using Single-Walled Carbon Nanotubes As Delivery Vehicles

VP4/VP56/VP35 Virus-like Particles Effectively Protect Grass Carp (Ctenopharyngodon idella) against GCRV-II Infection

Recombinant surface display vaccine enhances the immersion immune effect against grass carp reovirus in grass carp (Ctenopharyngodon idella)

Immunization with Recombinant Baculovirus Expressing the VP6 Protein of Grass Carp Reovirus Induces Immunity in Grass Carp

Recombinant Baculovirus-Produced Grass Carp Reovirus Virus-Like Particles as Vaccine Candidate That Provides Protective Immunity against GCRV Genotype II Infection in Grass Carp

Oral Vaccination of BacFish-vp6 Against Grass Carp Reovirus Evoking Antibody Response in Grass Carp.

Assessment of a natural grass carp reovirus genotype II avirulent strain GD1108 shows great potential as an avirulent live vaccine

An Oral Microencapsulated Vaccine Loaded by Sodium Alginate Effectively Enhances Protection Against GCRV Infection in Grass Carp (ctenopharyngodon Idella).

Single-walled Carbon Nanotubes As Candidate Recombinant Subunit Vaccine Carrier for Immunization of Grass Carp Against Grass Carp Reovirus.

Evaluation of SWCNTs-loaded DNA vaccine encoding predominant antigen epitope VP4-3 against type II GCRV